{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T08:21:01Z","timestamp":1790670061995,"version":"4.1.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Saf"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1007\/s40264-017-0579-1","type":"journal-article","created":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T14:05:00Z","timestamp":1501596300000},"page":"1259-1277","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["A Pharmacoepidemiology Database System for Monitoring Risk Due to the Use of Medicines by New Zealand Primary Care Patients"],"prefix":"10.1007","volume":"40","author":[{"given":"Andrew M.","family":"Tomlin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Reith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Woods","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hywel S.","family":"Lloyd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alesha","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John S.","family":"Fountain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murray W.","family":"Tilyard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,8,1]]},"reference":[{"key":"579_CR1","first-page":"131","volume-title":"Epidemiology\u2014current perspectives on research and practice","author":"C Torre","year":"2012","unstructured":"Torre C, Martins AP. Overview of pharmacoepidemiological databases in the assessment of medicines under real-life conditions. In: Lunet N, editor. Epidemiology\u2014current perspectives on research and practice. Rijeka: InTech; 2012. p. 131\u201354."},{"key":"579_CR2","doi-asserted-by":"crossref","first-page":"600","DOI":"10.7326\/0003-4819-153-9-201011020-00010","volume":"153","author":"PE Stang","year":"2010","unstructured":"Stang PE, Ryan PB, Racoosin JA, et al. Advancing the science for active surveillance: rationale and design for the Observational Medical Outcomes Partnership. Ann Intern Med. 2010;153:600\u20136.","journal-title":"Ann Intern Med"},{"key":"579_CR3","doi-asserted-by":"publisher","unstructured":"Huser V, DeFalco FJ, Schuemie M, et al. Multisite evaluation of a data quality tool for patient-level clinical datasets. eGEMs (Generating Evidence & Methods to improve patient outcomes). 2016;4(1):Article 24. doi:\n                        10.13063\/2327-9214.1239\n                        \n                    . \n                        https:\/\/egems.academyhealth.org\/articles\/abstract\/10.13063\/2327-9214.1239\/\n                        \n                    . Accessed 31 July 2017.","DOI":"10.13063\/2327-9214.1239"},{"key":"579_CR4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/pds.2053","volume":"20","author":"PM Coloma","year":"2011","unstructured":"Coloma PM, Schuemie MJ, Trifiro G, et al. Combining electronic healthcare databases in Europe to allow for large-scale drug safety monitoring: the EU-ADR Project. Pharmacoepidemiol Drug Saf. 2011;20:1\u201311.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"12","key":"579_CR5","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1002\/pds.2032","volume":"19","author":"LA Garc\u00eda Rodr\u00edguez","year":"2010","unstructured":"Garc\u00eda Rodr\u00edguez LA, Herings R, Johansson S. Use of multiple international healthcare databases for the detection of rare drug-associated outcomes: a pharmacoepidemiological programme comparing rosuvastatin with other marketed statins. Pharmacoepidemiol Drug Saf. 2010;19(12):1218\u201324.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"2","key":"579_CR6","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/j.1365-2125.2004.02106.x","volume":"58","author":"WG Goettsch","year":"2004","unstructured":"Goettsch WG, Janknegt R, Herings RM. Increased treatment failure after 3-days\u2019 courses of nitrofurantoin and trimethoprim for urinary tract infections in women: a population-based retrospective cohort study using the PHARMO database. Br J Clin Pharmacol. 2004;58(2):184\u20139.","journal-title":"Br J Clin Pharmacol"},{"issue":"3","key":"579_CR7","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1007\/s00198-010-1337-8","volume":"22","author":"S Pouwels","year":"2011","unstructured":"Pouwels S, Lalmohamed A, Souverein P, et al. Use of proton pump inhibitors and risk of hip\/femur fracture: a population-based case-control study. Osteoporos Int. 2011;22(3):903\u20139.","journal-title":"Osteoporos Int"},{"key":"579_CR8","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1038\/ki.2014.74","volume":"86","author":"ML Blank","year":"2014","unstructured":"Blank ML, Parkin L, Paul C, Herbison P. A nationwide nested case-control study indicates an increased risk of acute interstitial nephritis with proton pump inhibitor use. Kidney Int. 2014;86:837\u201344.","journal-title":"Kidney Int"},{"issue":"3","key":"579_CR9","first-page":"172","volume":"38","author":"C Grey","year":"2017","unstructured":"Grey C, Jackson R, Schmidt M, et al. One in four major ischaemic heart disease events are fatal and 60% are pre-hospital deaths: a national data-linkage study (ANZACS-QI 8). Eur Heart J. 2017;38(3):172\u201380.","journal-title":"Eur Heart J"},{"issue":"1","key":"579_CR10","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1093\/pubmed\/fdu116","volume":"38","author":"AM Tomlin","year":"2016","unstructured":"Tomlin AM, Gillies TD, Tilyard MW, Dovey SM. Variation in pharmaceutical costs of New Zealand general practices: a national database linkage study. J Public Health. 2016;38(1):138\u201346.","journal-title":"J Public Health."},{"issue":"1421","key":"579_CR11","first-page":"30","volume":"128","author":"S Bibby","year":"2015","unstructured":"Bibby S, Milne R, Beasley R. Hospital admissions for non-cystic fibrosis bronchiectasis in\u00a0New Zealand. NZ Med J. 2015;128(1421):30\u20138.","journal-title":"NZ Med J."},{"issue":"1\u20132","key":"579_CR12","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.healthpol.2013.02.008","volume":"112","author":"P Davis","year":"2013","unstructured":"Davis P, Milne B, Parker K, et al. Efficiency, effectiveness, equity (E3). Evaluating hospital performance in three dimensions. Health Policy. 2013;112(1\u20132):19\u201327.","journal-title":"Health Policy"},{"issue":"17","key":"579_CR13","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1177\/2047487316657671","volume":"23","author":"C Grey","year":"2016","unstructured":"Grey C, Jackson R, Wells S, et al. Ethnic differences in case fatality following an acute ischaemic heart disease event in\u00a0New Zealand: ANZACS-QI 13. Eur J Prev Cardiol. 2016;23(17):1823\u201330.","journal-title":"Eur J Prev Cardiol."},{"issue":"3","key":"579_CR14","doi-asserted-by":"crossref","first-page":"312","DOI":"10.4104\/pcrj.2013.00068","volume":"22","author":"TD Gillies","year":"2013","unstructured":"Gillies TD, Tomlin AM, Dovey SM, Tilyard MW. Ethnic disparities in asthma treatment and outcomes in children aged under 15\u00a0years: analysis of national databases. Prim Care Respir J. 2013;22(3):312\u20138.","journal-title":"Prim Care Respir J."},{"key":"579_CR15","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1001\/archinte.160.14.2093","volume":"160","author":"S Hernandez-Diaz","year":"2000","unstructured":"Hernandez-Diaz S, Rodriguez LA. Association between nonsteroidal anti-inflammatory drugs and upper gastrointestinal tract bleeding\/perforation. Arch Intern Med. 2000;160:2093\u20139.","journal-title":"Arch Intern Med"},{"issue":"7217","key":"579_CR16","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1136\/bmj.319.7217.1106","volume":"319","author":"FJ Abajo de","year":"1999","unstructured":"de Abajo FJ, Rodriguez LA, Montero D. Association between selective serotonin reuptake inhibitors and upper gastrointestinal bleeding: population-based case-control study. BMJ. 1999;319(7217):1106\u20139.","journal-title":"BMJ"},{"issue":"7314","key":"579_CR17","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1136\/bmj.323.7314.655","volume":"323","author":"C Walraven van","year":"2001","unstructured":"van Walraven C, Mamdani MM, Wells PS, Williams JI. Inhibition of serotonin uptake by antidepressants and upper gastrointestinal bleeding in elderly patients: a retrospective cohort study. BMJ. 2001;323(7314):655\u20138.","journal-title":"BMJ"},{"issue":"7","key":"579_CR18","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1111\/j.1365-2036.2006.02859.x","volume":"23","author":"S Wessinger","year":"2006","unstructured":"Wessinger S, Kaplan M, Choi L, et al. Increased use of selective serotonin reuptake inhibitors in patients admitted with gastrointestinal haemorrhage: a multi-centre retrospective analysis. Aliment Pharmacol Ther. 2006;23(7):937\u201344.","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"579_CR19","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1001\/archinte.163.1.59","volume":"163","author":"SO Dalton","year":"2003","unstructured":"Dalton SO, Johansen C, Mellemkjaer L, et al. Use of selective serotonin reuptake inhibitors and risk of upper gastrointestinal bleeding: population-based cohort study. Arch Intern Med. 2003;163(1):59\u201364.","journal-title":"Arch Intern Med"},{"issue":"7","key":"579_CR20","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1001\/archpsyc.65.7.795","volume":"65","author":"FJ Abajo de","year":"2008","unstructured":"de Abajo FJ, Garcia-Rodriguez LA. Risk of upper gastrointestinal tract bleeding associated with selective serotonin reuptake inhibitors and venlafaxine therapy: interaction with non-steroidal anti-inflammatory drugs and effect of acid-suppressing agents. Arch Gen Psychiatry. 2008;65(7):795\u2013803.","journal-title":"Arch Gen Psychiatry"},{"issue":"12","key":"579_CR21","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1136\/gut.2005.080754","volume":"55","author":"A Lanas","year":"2006","unstructured":"Lanas A, Garcia-Rodriguez LA, Arroyo MT, et al. Risk of upper gastrointestinal ulcer bleeding associated with selective cyclo-oxygenase-2-inhibitors, traditional non-aspirin non-steroidal anti-inflammatory drugs, aspirin and combinations. Gut. 2006;55(12):1731\u20138.","journal-title":"Gut"},{"issue":"12","key":"579_CR22","doi-asserted-by":"publisher","first-page":"e15721","DOI":"10.1371\/journal.pone.0015721","volume":"5","author":"ES Huang","year":"2010","unstructured":"Huang ES, Strate LL, Ho WW, et al. A prospective study of aspirin use and the risk of gastrointestinal bleeding in men. PLoS One. 2010;5(12):e15721. doi:\n                        10.1371\/journal.pone.0015721\n                        \n                    .","journal-title":"PLoS One"},{"key":"579_CR23","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/1471-2369-14-150","volume":"14","author":"DG Klepser","year":"2013","unstructured":"Klepser DG, Collier DS, Cochran GL. Proton pump inhibitors and acute kidney injury: a nested case-control study. BMC Nephrol. 2013;14:150. doi:\n                        10.1186\/1471-2369-14-150\n                        \n                    .","journal-title":"BMC Nephrol."},{"key":"579_CR24","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1002\/pds.3329","volume":"21","author":"CE Leonard","year":"2012","unstructured":"Leonard CE, Freeman CP, Newcomb CW, et al. Proton pump inhibitors and traditional nonsteroidal anti-inflammatory drugs and the risk of acute interstitial nephritis and acute kidney injury. Pharmacoepidemiol Drug Saf. 2012;21:1155\u201372.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"579_CR25","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1093\/aje\/kwj331","volume":"164","author":"V Schneider","year":"2006","unstructured":"Schneider V, Levesque LE, Zhang B, et al. Association of selective and conventional nonsteroidal antiinflammatory drugs with acute renal failure: a population-based nested case-control analysis. Am J Epidemiol. 2006;164:881\u20139.","journal-title":"Am J Epidemiol"},{"issue":"9","key":"579_CR26","doi-asserted-by":"publisher","first-page":"e2645","DOI":"10.1097\/MD.0000000000002645","volume":"95","author":"CI Chou","year":"2016","unstructured":"Chou CI, Shih CJ, Chen YT, et al. Adverse effects of oral nonselective and cyclooxygenase-2-selective NSAIDs on hospitalization for acute kidney injury: a nested case-control cohort study. Medicine. 2016;95(9):e2645. doi:\n                        10.1097\/MD.0000000000002645\n                        \n                    .","journal-title":"Medicine."},{"issue":"3","key":"579_CR27","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1161\/HYPERTENSIONAHA.114.05105","volume":"66","author":"CC Hsu","year":"2015","unstructured":"Hsu CC, Wang H, Hsu YH, et al. Use of nonsteroidal anti-inflammatory drugs and risk of chronic kidney disease in subjects with hypertension: a nationwide longitudinal cohort study. Hypertension. 2015;66(3):524\u201333.","journal-title":"Hypertension"},{"issue":"2","key":"579_CR28","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1001\/jamainternmed.2015.7193","volume":"176","author":"B Lazarus","year":"2016","unstructured":"Lazarus B, Chen Y, Wilson FP, et al. Proton pump inhibitor use and the risk of chronic kidney disease. JAMA Intern Med. 2016;176(2):238\u201346.","journal-title":"JAMA Intern Med."},{"issue":"10","key":"579_CR29","doi-asserted-by":"crossref","first-page":"3153","DOI":"10.1681\/ASN.2015121377","volume":"27","author":"Y Xie","year":"2016","unstructured":"Xie Y, Bowe B, Li T, et al. Proton pump inhibitors and risk of incident CKD and progression to ESRD. J Am Soc Nephrol. 2016;27(10):3153\u201363.","journal-title":"J Am Soc Nephrol"},{"key":"579_CR30","doi-asserted-by":"publisher","first-page":"i843","DOI":"10.1136\/bmj.i843","volume":"352","author":"M Inghammar","year":"2016","unstructured":"Inghammar M, Svanstrom H, Melbye M, et al. Oral fluoroquinolone use and serious arrhythmia: bi-national cohort study. BMJ. 2016;352:i843. doi:\n                        10.1136\/bmj.i843\n                        \n                    .","journal-title":"BMJ"},{"key":"579_CR31","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1056\/NEJMoa1003833","volume":"366","author":"WA Ray","year":"2012","unstructured":"Ray WA, Murray KT, Hall K, et al. Azithromycin and the risk of cardiovascular death. N Engl J Med. 2012;366:1881\u201390.","journal-title":"N Engl J Med"},{"issue":"2","key":"579_CR32","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1517\/14740338.2015.989210","volume":"14","author":"ZK Lu","year":"2015","unstructured":"Lu ZK, Yuan J, Li M, et al. Cardiac risks associated with antibiotics: azithromycin and levofloxacin. Expert Opin Drug Saf. 2015;14(2):295\u2013303.","journal-title":"Expert Opin Drug Saf."},{"key":"579_CR33","volume-title":"Guidelines for ATC classification and DDD assignment 2013","author":"WHO Collaborating Centre for Drug Statistics Methodology","year":"2012","unstructured":"WHO Collaborating Centre for Drug Statistics Methodology. Guidelines for ATC classification and DDD assignment 2013. Oslo: WHO; 2012."},{"key":"579_CR34","doi-asserted-by":"publisher","first-page":"i4857","DOI":"10.1136\/bmj.i4857","volume":"354","author":"A Arfe","year":"2016","unstructured":"Arfe A, Scotti L, Varas-Lorenzo C, et al. Non-steroidal anti-inflammatory drugs and risk of heart failure in four European countries: nested case-control study. BMJ. 2016;354:i4857. doi:\n                        10.1136\/bmj.i4857\n                        \n                    .","journal-title":"BMJ"},{"key":"579_CR35","unstructured":"Information Services Division NHS Scotland. Measuring Long-Term Conditions in Scotland. ISD Scotland. 2008. \n                        https:\/\/www.isdscotland.org\/Health-Topics\/Hospital-Care\/Diagnoses\/2008_08_14_LTC_full_report.pdf\n                        \n                    . Accessed 4 Apr 2017."},{"issue":"9836","key":"579_CR36","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0140-6736(12)60240-2","volume":"380","author":"K Barnett","year":"2012","unstructured":"Barnett K, Mercer SW, Norbury M, et al. Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study. Lancet. 2012;380(9836):37\u201343.","journal-title":"Lancet"},{"issue":"7","key":"579_CR37","first-page":"631","volume":"86","author":"M Rahman","year":"2012","unstructured":"Rahman M, Shad F, Smith MC. Acute kidney injury: a guide to diagnosis and management. Am Fam Physician. 2012;86(7):631\u20139.","journal-title":"Am Fam Physician"},{"issue":"12","key":"579_CR38","first-page":"871","volume":"51","author":"H Khalili","year":"2013","unstructured":"Khalili H, Bairami S, Kargar M. Antibiotics induced acute kidney injury: incidence, risk factors, onset time and outcome. Acta Med Iran. 2013;51(12):871\u20138.","journal-title":"Acta Med Iran."},{"key":"579_CR39","unstructured":"Medsafe. Drug-induced QT prolongation and Torsades de Pointes\u2014the facts. \n                        http:\/\/www.medsafe.govt.nz\/profs\/PUArticles\/DrugInducedQTProlongation.htm\n                        \n                    . Accessed 4 Apr 2017."},{"issue":"8900","key":"579_CR40","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S0140-6736(94)91843-0","volume":"343","author":"LA Garcia Rodriguez","year":"1994","unstructured":"Garcia Rodriguez LA, Jick H. Risk of upper gastrointestinal bleeding and perforation associated with non-steroidal anti-inflammatory drugs. Lancet. 1994;343(8900):769\u201372.","journal-title":"Lancet"},{"key":"579_CR41","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/0895-4356(92)90133-8","volume":"45","author":"RA Deyo","year":"1992","unstructured":"Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45:613\u20139.","journal-title":"J Clin Epidemiol"},{"key":"579_CR42","unstructured":"New Zealand Casemix Project Group. The New Zealand casemix system: an overview. December 2015 v1.2. \n                        https:\/\/www.health.govt.nz\/publication\/new-zealand-casemix-system-overview-0\n                        \n                    . Accessed 7 July 2017."},{"key":"579_CR43","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1002\/pds.1968","volume":"19","author":"RM Mera","year":"2010","unstructured":"Mera RM, Beach KJ, Powell GE, Pattishall EN. Semi-automated risk estimation using large databases: quinolones and clostridium difficile associated diarrhea. Pharmacoepidemiol Drug Saf. 2010;19:610\u20137.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"579_CR44","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1002\/pds.1836","volume":"18","author":"G Trifiro","year":"2009","unstructured":"Trifiro G, Pariente A, Coloma PM, et al. Data mining on electronic health record databases for signal detection in pharmacovigilance: which events to monitor? Pharmacoepidemiol Drug Saf. 2009;18:1176\u201384.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"579_CR45","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1002\/pds.3197","volume":"21","author":"PM Coloma","year":"2012","unstructured":"Coloma PM, Trifiro G, Schuemie MJ, et al. Electronic healthcare databases for active drug safety surveillance: is there enough leverage? Pharmacoepidemiol Drug Saf. 2012;21:611\u201321.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"3","key":"579_CR46","doi-asserted-by":"publisher","first-page":"e67","DOI":"10.1371\/journal.pmed.0050067","volume":"5","author":"J Vandenbroucke","year":"2008","unstructured":"Vandenbroucke J. Observational research, randomised trials, and two views of medical science. PloS Med. 2008;5(3):e67. doi:\n                        10.1371\/journal.pmed.0050067\n                        \n                    .","journal-title":"PloS Med."},{"key":"579_CR47","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1503\/cmaj.050873","volume":"174","author":"PN Papanikolaou","year":"2006","unstructured":"Papanikolaou PN, Christidi GD, Ioannidis JP. Comparison of evidence on harms of medical interventions in randomized and nonrandomized studies. CMAJ. 2006;174:635\u201341.","journal-title":"CMAJ"},{"key":"579_CR48","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1503\/cmaj.051484","volume":"174","author":"JP Vandenbroucke","year":"2006","unstructured":"Vandenbroucke JP. What is the best evidence for determining harms of medical treatment? CMAJ. 2006;174:645\u20136.","journal-title":"CMAJ"}],"container-title":["Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40264-017-0579-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40264-017-0579-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40264-017-0579-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,11,15]],"date-time":"2017-11-15T05:29:42Z","timestamp":1510723782000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40264-017-0579-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,1]]},"references-count":48,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["579"],"URL":"https:\/\/doi.org\/10.1007\/s40264-017-0579-1","relation":{},"ISSN":["0114-5916","1179-1942"],"issn-type":[{"value":"0114-5916","type":"print"},{"value":"1179-1942","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,1]]}}}